-
Evaluation of a targeted anti-αvβ3 integrin near-infrared fluorescent dye for fluorescence-guided resection of naturally occurring soft tissue sarcomas in dogs Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-10-22 Patricia Beer, Paula Grest, Christiane Krudewig, Chris Staudinger, Stefanie Ohlerth, Carla Rohrer Bley, Armin Jarosch, Houria Ech-Cherif, Enni Markkanen, Brian Park, Mirja Christine Nolff
-
Hybrid cardiovascular imaging. A clinical consensus statement of the european association of nuclear medicine (EANM) and the european association of cardiovascular imaging (EACVI) of the ESC Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-10-22 Federico Caobelli, Marc R. Dweck, Domenico Albano, Olivier Gheysens, Panagiotis Georgoulias, Stephan Nekolla, Olivier Lairez, Lucia Leccisotti, Marc Lubberink, Samia Massalha, Carmela Nappi, Christoph Rischpler, Antti Saraste, Fabien Hyafil
-
Remote ischemic periconditioning suppresses cardiac sympathetic activation in acute myocardial infarction: a randomized controlled trial Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-10-22 Takumi Kondo, Masahiro Seo, Tetsuya Watanabe, Takahisa Yamada, Takashi Morita, Masato Kawasaki, Atsushi Kikuchi, Tsutomu Kawai, Yuji Nishimoto, Jun Nakamura, Takeshi Fujita, Masanao Tanichi, Yongchol Chang, Yasushi Sakata, Masatake Fukunami
-
Imaging of acute aortic dissection by [18F]AlF-NOTA-FAPI PET/CT Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-10-21 Yao Lu, Yuan Xue, Hao Han, Xiaoli Zhang, Haiyang Li
-
Disease-informed Adaptation of Vision-Language Models IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-10-21 Jiajin Zhang, Ge Wang, Mannudeep K. Kalra, Pingkun Yan
-
Effective Semi-Supervised Medical Image Segmentation with Probabilistic Representations and Prototype Learning IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-10-21 Yuchen Yuan, Xi Wang, Xikai Yang, Pheng-Ann Heng
-
First-in-human study of dosimetry, safety and efficacy for [177Lu]Lu-P15-073: a novel bisphosphonate-based radioligand therapy (RLT) agent for bone metastases Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-10-18 Ruiyue Zhao, Jie Lv, Mingzhao Li, Siran Xu, Wenhua Liang, Xinqing Lin, Di Gu, Guohua Zeng, Wenbin Jin, Qingsong Yan, Huizhen Zhong, David Alexoff, Karl Ploessl, Lin Zhu, Hank F. Kung, Xinlu Wang
-
Enhancing the tissue penetration to improve sonodynamic immunotherapy for pancreatic ductal adenocarcinoma using membrane-camouflaged nanoplatform Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-10-18 Jiawei Du, Xin Chen, Xiaoxuan Xu, Ziting Que, Mengyan Zhai, Qinyanqiu Xiang, Zhiwei Zhang, Zhiqi Zhang, Yong Shao, Xue Yang, Fengqin Miao, Jianqiong Zhang, Jinbing Xie, Shenghong Ju
-
SNMMI Procedure Standard/EANM Practice Guideline for Brain [18F]FDG PET Imaging, Version 2.0 J Nucl. Med. (IF 9.1) Pub Date : 2024-10-17 Javier Arbizu, Silvia Morbelli, Satoshi Minoshima, Henryk Barthel, Philip Kuo, Donatienne Van Weehaeghe, Neil Horner, Patrick M. Colletti, Eric Guedj
PREAMBLE The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and professional organization founded in 1954 to promote the science, technology, and practical application of nuclear medicine. The European Association of Nuclear Medicine (EANM) is a professional nonprofit medical association that facilitates communication worldwide between individuals pursuing
-
Improved Localization of Insulinomas Using 68Ga-NODAGA-Exendin-4 PET/CT J Nucl. Med. (IF 9.1) Pub Date : 2024-10-17 Marti Boss, Olof Eriksson, Kirsi Mikkola, Annemarie Eek, Maarten Brom, Mijke Buitinga, Adrienne H. Brouwers, Irina Velikyan, Beatrice Waser, Saila Kauhanen, Olof Solin, Camille Marciniak, Barbro Eriksson, Jean-Claude Reubi, Cyrielle Aveline, Damian Wild, Francois Pattou, Jean-Noel Talbot, Johannes Hofland, Anders Sundin, Pirjo Nuutila, John Hermans, Martin Gotthardt
Visual Abstract
-
FedLPPA: Learning Personalized Prompt and Aggregation for Federated Weakly-supervised Medical Image Segmentation IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-10-18 Li Lin, Yixiang Liu, Jiewei Wu, Pujin Cheng, Zhiyuan Cai, Kenneth K. Y. Wong, Xiaoying Tang
-
DPI-MoCo: Deep Prior Image Constrained Motion Compensation Reconstruction for 4D CBCT IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-10-18 Dianlin Hu, ChenCheng Zhang, Xuanjia Fei, Yi Yao, Yan Xi, Jin Liu, Yikun Zhang, Gouenou Coatrieux, Jean Louis Coatrieux, Yang Chen
-
STARTS: A self-adapted spatio-temporal framework for automatic E/MEG source imaging IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-10-18 Zhao Feng, Cuntai Guan, Ruifeng Zheng, Yu Sun
-
Core-Periphery Multi-Modality Feature Alignment for Zero-Shot Medical Image Analysis IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-10-17 Xiaowei Yu, Lu Zhang, Zihao Wu, Dajiang Zhu
-
MRI Super-Resolution with Partial Diffusion Models IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-10-17 Kai Zhao, Kaifeng Pang, Alex Ling Yu Hung, Haoxin Zheng, Ran Yan, Kyunghyun Sung
-
[68Ga]Ga-LNC1007 versus 2-[18F]FDG in the evaluation of patients with metastatic differentiated thyroid cancer: a head-to-head comparative study Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-10-15 Yun Chen, Shan Zheng, Jie Zang, Zezhong Shao, Dongmei Tu, Qun Liu, Xiaoyuan Chen, Weibing Miao, Jingjing Zhang
-
Using a novel PSMA-PET and PSA-based model to enhance the diagnostic accuracy for clinically significant prostate cancer and avoid unnecessary biopsy in men with PI-RADS ≤ 3 MRI Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-10-15 Yujia Li, Jian Li, Jinhui Yang, Ling Xiao, Ming Zhou, Yi Cai, Axel Rominger, Kuangyu Shi, Robert Seifert, Xiaomei Gao, Yongxiang Tang, Shuo Hu
-
PET/CT imaging of differentiated and medullary thyroid carcinoma using the novel SSTR-targeting peptide [18F]SiTATE – first clinical experiences Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-10-15 Sophie C. Kunte, Vera Wenter, Johannes Toms, Simon Lindner, Marcus Unterrainer, Friederike Eilsberger, Klaus Jurkschat, Carmen Wängler, Björn Wängler, Ralf Schirrmacher, Maximilian W. Tiling, Gabriel T. Sheikh, Dirk Mehrens, Matthias Brendel, Johannes Rübenthaler, Christoph J. Auernhammer, Christine Spitzweg, Lena M. Unterrainer, Adrien Holzgreve
-
Persistent dysfunctions of brain metabolic connectivity in long-covid with cognitive symptoms Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-10-15 Anna Lisa Martini, Giulia Carli, Silvia Paola Caminiti, Lorenzo Kiferle, Andrea Leo, Daniela Perani, Stelvio Sestini
-
Coronary artery calcium measurement on attenuation correction computed tomography using artificial intelligence: correlation with coronary flow capacity and prognosis Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-10-15 Sang-Geon Cho, Jong Eun Lee, Kyung Hoon Cho, Ki-Seong Park, Jahae Kim, Jang Bae Moon, Kang Bin Kim, Ju Han Kim, Ho-Chun Song
-
Egesta Lopci, Luigi Mansi (editors). Advanced imaging and therapy in neuro-oncology, 1st edition. Springer, 2024. ISBN: 978-3-031-59340-6. Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-10-15 Silvia Morbelli
-
Epileptogenic plis de passage in the postcentral sulcus identified by [18 F]FDG PET/MR Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-10-14 Fanglan Li, Yingying Tang, Heng Zhang, Qianrui Li, Jiani Chen
-
Learning the Imaging Model of Speed-of-Sound Reconstruction via a Convolutional Formulation IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-10-14 Can Deniz Bezek, Maxim Haas, Richard Rau, Orcun Goksel
-
Novel astatine (211At)-labelled prostate-specific membrane antigen ligand with a neopentyl-glycol structure: evaluation of stability, efficacy, and safety using a prostate cancer xenograft model Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-10-12 Kei Yaginuma, Kazuhiro Takahashi, Seiji Hoshi, Taiki Joho, Saki Shimoyama, Naoko Hasegawa, Koki Hasegawa, Songji Zhao, Naoyuki Ukon, Syunta Makabe, Satoru Meguro, Akifumi Onagi, Kanako Matsuoka, Soichiro Ogawa, Motohide Uemura, Tomoki Yamashita, Hiroyuki Suzuki, Tomoya Uehara, Yoshiyuki Kojima
-
Preclinical evaluation of 225Ac-labeled minigastrin analog DOTA-CCK-66 for Targeted Alpha Therapy Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-10-11 Nadine Holzleitner, Meryl Vilangattil, Abir Swaidan, Clara Diaz Garcia-Prada, Marco F. Taddio, Pauline Jeanjean, Christine E. Mona, Constantin Lapa, Angela Casini, Thomas Günther, Giuseppe Carlucci
-
Fluorescence detection of pituitary neuroendocrine tumour during endoscopic transsphenoidal surgery using bevacizumab-800CW: a non-randomised, non-blinded, single centre feasibility and dose finding trial [DEPARTURE trial] Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-10-11 I. Schmidt, R. A. Vergeer, M. R. Postma, G. van den Berg, A. J. Sterkenburg, A. G. W. Korsten-Meijer, R. A. Feijen, S. Kruijff, A. P. van Beek, W. F. A. den Dunnen, D. J. Robinson, J. M. C. van Dijk, W. B. Nagengast, J. M. A. Kuijlen
-
Granzyme B PET/CT Imaging Evaluates Early Response to Immunotherapy in Gastric Cancer J Nucl. Med. (IF 9.1) Pub Date : 2024-10-10 Qiufang Liu, Xiaoping Xu, Ziyi Yang, Jianping Zhang, Jindian Li, Ying Qiao, Silong Hu, Xiaosheng Liu, Weijian Guo, Shaoli Song
In several malignancies, only a limited number of patients respond to immune checkpoint inhibitors. Predicting and monitoring responses to these inhibitors represent an unmet clinical need. Here, we developed a PET/CT probe targeting granzyme B, [68Ga]Ga-NOTA-Gly-Gly-Gly-Ile-Glu-Pro-Asp-CHO (GSI), and aimed to investigate whether it can be used to monitor the effects of immune checkpoint inhibitors
-
Impact of 18F-FDG PET/MRI on Therapeutic Management of Women with Newly Diagnosed Breast Cancer: Results from a Prospective Double-Center Trial J Nucl. Med. (IF 9.1) Pub Date : 2024-10-10 Kai Jannusch, Lale Umutlu, Julian Kirchner, Nils-Martin Bruckmann, Janna Morawitz, Ken Herrmann, Wolfgang Peter Fendler, Ann-Kathrin Bittner, Oliver Hoffmann, Svjetlana Mohrmann, Eugen Ruckhäberle, Martin Stuschke, Werner Schmid, Frederik Giesel, Lena Häberle, Irene Esposito, Wilfried Budach, Johannes Grueneisen, Christiane Matuschek, Bernd Kowall, Andreas Stang, Gerald Antoch, Christian Buchbender
Our rationale was to investigate whether 18F-FDG PET/MRI in addition to (guideline-recommended) conventional staging leads to changes in therapeutic management in patients with newly diagnosed breast cancer and compare the diagnostic accuracy of 18F-FDG PET/MRI with that of conventional staging for determining the Union for International Cancer Control (UICC) stage. Methods: In this prospective, double-center
-
uPAR Immuno-PET in Pancreatic Cancer, Aging, and Chemotherapy-Induced Senescence J Nucl. Med. (IF 9.1) Pub Date : 2024-10-10 Edwin C. Pratt, Riccardo Mezzadra, Amanda Kulick, Spencer Kaminsky, Zachary V. Samuels, Angelique Loor, Elisa de Stanchina, Scott W. Lowe, Jason S. Lewis
Visual Abstract
-
EANM/SNMMI guideline/procedure standard for [18F]FDG hybrid PET use in infection and inflammation in adults v2.0 Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-10-10 Gad Abikhzer, Giorgio Treglia, Matthieu Pelletier-Galarneau, John Buscombe, Arturo Chiti, Elizabeth H. Dibble, Andor W. J. M. Glaudemans, Christopher J. Palestro, Mike Sathekge, Alberto Signore, Francois Jamar, Ora Israel, Olivier Gheysens
Introduction Hybrid [18F]FDG PET imaging is currently the method of choice for a wide variety of infectious and inflammatory disorders and was recently adopted in several clinical guidelines. A large amount of evidence-based articles, guidelines and appropriate use criteria have been published since the first version of this guideline in 2013. Purpose To provide updated evidence-based information to
-
CQformer: Learning Dynamics Across Slices in Medical Image Segmentation IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-10-10 Shengjie Zhang, Xin Shen, Xiang Chen, Ziqi Yu, Bohan Ren, Haibo Yang, Xiao-Yong Zhang, Yuan Zhou
-
Spiral volumetric optoacoustic tomography of reduced oxygen saturation in the spinal cord of M83 mouse model of Parkinson’s disease Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-10-09 Benjamin F. Combes, Sandeep Kumar Kalva, Pierre-Louis Benveniste, Agathe Tournant, Man Hoi Law, Joshua Newton, Maik Krüger, Rebecca Z. Weber, Inês Dias, Daniela Noain, Xose Luis Dean-Ben, Uwe Konietzko, Christian R. Baumann, Per-Göran Gillberg, Christoph Hock, Roger M. Nitsch, Julien Cohen-Adad, Daniel Razansky, Ruiqing Ni
-
Non-invasive Deep-Brain Imaging with 3D Integrated Photoacoustic Tomography and Ultrasound Localization Microscopy (3D-PAULM) IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-10-09 Yuqi Tang, Nanchao Wang, Zhijie Dong, Matthew Lowerison, Angela Del Aguila, Natalie Johnston, Tri Vu, Chenshuo Ma, Yirui Xu, Wei Yang, Pengfei Song, Junjie Yao
-
Preclinical evaluation and pilot clinical study of [68Ga]Ga-NOTA-H006 for non-invasive PET imaging of 5T4 oncofetal antigen Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-10-08 Yingfang He, Ruhua Tian, Dong Xu, Yanfei Wu, Sa Rina, Tengxiang Chen, Yihui Guan, Tianwu Xie, Tianlei Ying, Fang Xie, Junbin Han
-
Pharmacokinetic analysis and simplified uptake measures for tumour lesion [18F]F-AraG PET imaging in patients with non-small cell lung cancer Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-10-08 Jessica E. Wijngaarden, Maarten Slebe, Johanna E. E. Pouw, Daniela E. Oprea-Lager, Robert C. Schuit, Chris Dickhoff, Jelena Levi, Albert D. Windhorst, C. Willemien Menke-van der Houven van Oordt, Andrea Thiele, Idris Bahce, Ronald Boellaard, Maqsood Yaqub
-
GlandSAM: Injecting Morphology Knowledge into Segment Anything Model for Label-free Gland Segmentation IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-10-08 Qixiang Zhang, Yi Li, Cheng Xue, Haonan Wang, Xiaomeng Li
-
Pre-treatment [18F]FDG PET/CT biomarkers for the prediction of antibody–drug conjugates efficacy in metastatic breast cancer Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-10-07 Romain-David Seban, Laurence Champion, Alexandre De Moura, Florence Lerebours, Delphine Loirat, Jean-Yves Pierga, Lounes Djerroudi, Thomas Genevee, Virginie Huchet, Nina Jehanno, Francois-Clement Bidard, Irene Buvat
-
[18F]FDG PET for mapping the cerebral glucose metabolic characteristics of drug-sensitive and drug-resistant epilepsy in pediatric patients Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-10-07 Daoyan Hu, Congcong Yu, Xiaohui Zhang, Yan Zhong, Yuankai Zhu, Mei Tian, Hong Zhang
-
Solving Zero-Shot Sparse-View CT Reconstruction With Variational Score Solver IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-10-07 Linchao He, Wenchao Du, Peixi Liao, Fenglei Fan, Hu Chen, Hongyu Yang, Yi Zhang
-
Morphology-based non-rigid registration of coronary computed tomography and intravascular images through virtual catheter path optimization IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-10-07 Karim Kadry, Max L. Olender, Andreas Schuh, Abhishek Karmakar, Kersten Petersen, Michiel Schaap, David Marlevi, Adam UpdePac, Takuya Mizukami, Charles Taylor, Elazer R. Edelman, Farhad R. Nezami
-
Unleash the Power of State Space Model for Whole Slide Image with Local Aware Scanning and Importance Resampling IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-10-07 Yanyan Huang, Weiqin Zhao, Yu Fu, Lingting Zhu, Lequan Yu
-
Pre-operative dual-time-point [18F]FET PET differentiates CDKN2A/B loss and PIK3CA mutation status in adult-type diffuse glioma: a single-center prospective study Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-10-04 Dong Yun Lee, Jungsu S. Oh, Jeong Won Kim, Minyoung Oh, Seung Jun Oh, Seungjoo Lee, Young-Hoon Kim, Jeong Hoon Kim, Soo Jeong Nam, Sang Woo Song, Jae Seung Kim
-
Association of Free-to-Total PSA Ratio and 18F-DCFPyL Prostate-Specific Membrane Antigen PET/CT Findings in Patients with Biochemical Recurrence After Radical Prostatectomy: A Prospective Single-Center Study J Nucl. Med. (IF 9.1) Pub Date : 2024-10-03 Rui M. Bernardino, Katherine Lajkosz, Leyi B. Yin, Rashid K. Sayyid, Marian Wettstein, Harkanwal Randhawa, Jessica G. Cockburn, Sayeed Ahmed, Rosita Thomassian, Eleftherios Diamandis, Ur Metser, Alejandro Berlin, Neil E. Fleshner
In Canada and across the globe, access to PSMA PET/CT is limited and expensive. For patients with biochemical recurrence (BCR) after treatment for prostate cancer, novel strategies are needed to better stratify patients who may or may not benefit from a PSMA PET scan. The role of the free-to-total prostate-specific antigen (PSA) ratio (FPSAR) in posttreatment prostate cancer, specifically in the PSMA
-
Routine Use of [64Cu]Cu-DOTATATE PET/CT in a Neuroendocrine Tumor Center: Referral Patterns and Image Results of 2,249 Consecutive Scans J Nucl. Med. (IF 9.1) Pub Date : 2024-10-03 Esben Andreas Carlsen, Mathias Loft, Camilla Bardram Johnbeck, Ulrich Knigge, Seppo W. Langer, Jann Mortensen, Lotte Enevoldsen, Peter Oturai, Andreas Kjaer
The role of somatostatin receptor (SSTR) PET/CT, using 68Ga-based tracers or [64Cu]Cu-DOTATATE (64Cu-DOTATATE), in the management of patients with neuroendocrine neoplasm (NEN) is guided by appropriate use criteria (AUC). In this study, we performed systematic analyses of referral patterns and image findings of routine 64Cu-DOTATATE PET/CT scans to support AUC development. Methods: We included all
-
Impact of 18F-FES PET/CT on Clinical Decisions in the Management of Recurrent or Metastatic Breast Cancer J Nucl. Med. (IF 9.1) Pub Date : 2024-10-03 Jeongryul Ryu, Jaewon Hyung, Sangwon Han, Jae Ho Jeong, Sae Byul Lee, Tae-Kyung Robyn Yoo, Jisun Kim, Hee Jeong Kim, Il Yong Chung, Beom Seok Ko, Jong Won Lee, Byung Ho Son, Hyehyun Jeong, Jin-Hee Ahn, Kyung Hae Jung, Sung-Bae Kim, Dae Hyuk Moon
The clinical impact of 16α-18F-fluoro-17β-estradiol (18F-FES) PET/CT on patient management has not been well investigated. The aim of this study was to assess the clinical impact of 18F-FES PET/CT on the management of patients with recurrent or metastatic breast cancer. Methods: Study subjects were identified retrospectively from a database of a prospective trial for postmarketing surveillance of 18F-FES
-
Preclinical Evaluation of 226Ac as a Theranostic Agent: Imaging, Dosimetry, and Therapy J Nucl. Med. (IF 9.1) Pub Date : 2024-10-03 Helena Koniar, Luke Wharton, Aidan Ingham, Ana Paulina Morales Oliver, Helen Merkens, Cristina Rodríguez-Rodríguez, Peter Kunz, Valery Radchenko, Hua Yang, Arman Rahmim, Carlos Uribe, Paul Schaffer
226Ac (t½ = 29.37 h) has been proposed as a theranostic radioisotope leveraging both its diagnostic γ-emissions and therapeutic α-emissions. 226Ac emits 158 and 230 keV γ-photons ideal for quantitative SPECT imaging and acts as an in vivo generator of 4 high-energy α-particles. Because of these nuclear decay properties, 226Ac has potential to act as a standalone theranostic isotope. In this proof-of-concept
-
Cardiac Neuroendocrine Tumor Metastases on 68Ga-DOTATATE PET/CT: Identification and Prognostic Significance J Nucl. Med. (IF 9.1) Pub Date : 2024-10-03 Hwan Lee, Ahmad S. Alhamshari, Vandan Patel, Abhijit Bhattaru, Chaitanya Rojulpote, Mahesh K. Vidula, Daniel A. Pryma, Paco E. Bravo
Neuroendocrine tumor (NET) metastases to the heart are found in 1%–4% of NET patients and have been reported primarily in the form of individual cases. We investigated the prevalence, clinical characteristics, imaging features, and outcomes of NET patients with cardiac metastases on 68Ga-DOTATATE PET/CT. Methods: 68Ga-DOTATATE PET/CT of 490 consecutive patients from a single institution were retrospectively
-
Validation of an Artificial Intelligence–Based Prediction Model Using 5 External PET/CT Datasets of Diffuse Large B-Cell Lymphoma J Nucl. Med. (IF 9.1) Pub Date : 2024-10-03 Maria C. Ferrández, Sandeep S.V. Golla, Jakoba J. Eertink, Sanne E. Wiegers, Gerben J.C. Zwezerijnen, Martijn W. Heymans, Pieternella J. Lugtenburg, Lars Kurch, Andreas Hüttmann, Christine Hanoun, Ulrich Dührsen, Sally F. Barrington, N. George Mikhaeel, Luca Ceriani, Emanuele Zucca, Sándor Czibor, Tamás Györke, Martine E.D. Chamuleau, Josée M. Zijlstra, Ronald Boellaard
The aim of this study was to validate a previously developed deep learning model in 5 independent clinical trials. The predictive performance of this model was compared with the international prognostic index (IPI) and 2 models incorporating radiomic PET/CT features (clinical PET and PET models). Methods: In total, 1,132 diffuse large B-cell lymphoma patients were included: 296 for training and 836
-
Correlation of FAPI PET Uptake with Immunohistochemistry in Explanted Lungs from Patients with Advanced Interstitial Lung Disease J Nucl. Med. (IF 9.1) Pub Date : 2024-10-03 Masatoshi Hotta, Grace Hyun J. Kim, Vilasinee Rerkpichaisuth, Pang Yu Teng, Wesley R. Armstrong, Giuseppe Carlucci, Magnus Dahlbom, Fereidoun Abtin, Shahrzad M. Lari, Gregory A. Fishbein, Johannes Czernin, Elizabeth R. Volkmann, S. Sam Weigt, Jeremie Calais
Recent studies have demonstrated promising results of fibroblast activation protein (FAP) inhibitor (FAPI) PET in prognosticating and monitoring interstitial lung diseases (ILDs). As a first step toward successful translation, our primary aim was to validate the FAPI PET uptake through immunohistochemistry in patients with advanced ILD who underwent lung transplantation after a FAPI PET scan. Methods:
-
The Updated Registry of Fast Myocardial Perfusion Imaging with Next-Generation SPECT (REFINE SPECT 2.0) J Nucl. Med. (IF 9.1) Pub Date : 2024-10-03 Robert J.H. Miller, Mark Lemley, Aakash Shanbhag, Giselle Ramirez, Joanna X. Liang, Valerie Builoff, Paul Kavanagh, Tali Sharir, M. Timothy Hauser, Terrence D. Ruddy, Mathews B. Fish, Timothy M. Bateman, Wanda Acampa, Andrew J. Einstein, Sharmila Dorbala, Marcelo F. Di Carli, Attila Feher, Edward J. Miller, Albert J. Sinusas, Julian Halcox, Monica Martins, Philipp A. Kaufmann, Damini Dey, Daniel S
The Registry of Fast Myocardial Perfusion Imaging with Next-Generation SPECT (REFINE SPECT) has been expanded to include more patients and CT attenuation correction imaging. We present the design and initial results from the updated registry. Methods: The updated REFINE SPECT is a multicenter, international registry with clinical data and image files. SPECT images were processed by quantitative software
-
Best Patient Care Practices for Administering PSMA-Targeted Radiopharmaceutical Therapy J Nucl. Med. (IF 9.1) Pub Date : 2024-10-03 Jeremie Calais, Michael J. Morris, Ayse Tuba Kendi, Arash Rezazadeh Kalebasty, Ronald Tutrone, Michael J. Anderson, Oliver Sartor
Optimal patient management protocols for metastatic castration-resistant prostate cancer (mCRPC) are poorly defined and even further complexified with new therapy approvals, such as radiopharmaceuticals. The prostate-specific membrane antigen (PSMA)–targeted agent 177Lu vipivotide tetraxetan ([177Lu]Lu-PSMA-617), approved after the phase III VISION study, presents physicians with additional aspects
-
GobletNet: Wavelet-Based High-Frequency Fusion Network for Semantic Segmentation of Electron Microscopy Images IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-10-04 Yanfeng Zhou, Lingrui Li, Chenlong Wang, Le Song, Ge Yang
-
A gradient-based approach to fast and accurate head motion compensation in cone-beam CT IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-10-04 Mareike Thies, Fabian Wagner, Noah Maul, Haijun Yu, Manuela Goldmann Meier, Linda-Sophie Schneider, Mingxuan Gu, Siyuan Mei, Lukas Folle, Alexander Preuhs, Michael Manhart, Andreas Maier
-
Geometry-Aware Attenuation Learning for Sparse-View CBCT Reconstruction IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-10-04 Zhentao Liu, Yu Fang, Changjian Li, Han Wu, Yuan Liu, Dinggang Shen, Zhiming Cui
-
AttriPrompter: Auto-Prompting with Attribute Semantics for Zero-shot Nuclei Detection via Visual-Language Pre-trained Models. IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-10-03 Yongjian Wu, Yang Zhou, Jiya Saiyin, Bingzheng Wei, Maode Lai, Jianzhong Shou, Yan Xu
-
SPIRiT-Diffusion: Self-Consistency Driven Diffusion Model for Accelerated MRI IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-10-03 Zhuo-Xu Cui, Chentao Cao, Yue Wang, Sen Jia, Jing Cheng, Xin Liu, Hairong Zheng, Dong Liang, Yanjie Zhu
-
Multi-Organ Foundation Model for Universal Ultrasound Image Segmentation with Task Prompt and Anatomical Prior IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-10-03 Haobo Chen, Yehua Cai, Changyan Wang, Lin Chen, Bo Zhang, Hong Han, Yuqing Guo, Hong Ding, Qi Zhang
-
Visual reading for [18F]Florzolotau Tau PET scans in progressive supranuclear palsy Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-10-01 Feng-Tao Liu, Jia-Ying Lu, Xin-Yi Li, Jing-Jie Ge, Yi-Min Sun, Tzu-Chen Yen, Fang-Yang Jiao, Ming-Jia Chen, Jun Zhao, Rui-Xin Yao, Gan Tang, Hao Xu, Xiao-Li Lan, Jie Lu, Rui-Xue Cui, Matthias Brendel, Kuangyu Shi, Yi-Hui Guan, Axel Rominger, Jian Wang, Chuan-Tao Zuo
-
Long-term trends in total administered radiation dose from brain [18F]FDG-PET in children with drug-resistant epilepsy Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-10-01 Antonio G. Gennari, Stephan Waelti, Moritz Schwyzer, Valerie Treyer, Alexia Rossi, Thomas Sartoretti, Alexander Maurer, Georgia Ramantani, Ruth Tuura O’Gorman, Christian J. Kellenberger, Martin W. Hüllner, Michael Messerli
-
Ultrashort Oncologic Whole-Body [18F]FDG Patlak Imaging Using LAFOV PET J Nucl. Med. (IF 9.1) Pub Date : 2024-10-01 Joyce van Sluis, Johannes H. van Snick, Andor W.J.M. Glaudemans, Riemer H.J.A. Slart, Walter Noordzij, Adrienne H. Brouwers, Rudi A.J.O. Dierckx, Adriaan A. Lammertsma, Charalampos Tsoumpas, Ronald Boellaard
Methods to shorten [18F]FDG Patlak PET imaging procedures ranging from 65–90 to 20–30 min after injection, using a population-averaged input function (PIF) scaled to patient-specific image-derived input function (IDIF) values, were recently evaluated. The aim of the present study was to explore the feasibility of ultrashort 10-min [18F]FDG Patlak imaging at 55–65 min after injection using a PIF combined